Could a diabetes pill ease heart failure in fontan patients?
NCT ID NCT05741658
First seen Jan 06, 2026 · Last updated May 01, 2026 · Updated 17 times
Summary
This study tests whether a daily pill called dapagliflozin can prevent heart failure from getting worse in adults with Fontan circulation. About 29 participants will take the drug for 4 weeks to see if it lowers blood pressure in the veins and improves exercise ability. The goal is to find a simple treatment that helps people with this rare heart condition feel better and stay active.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ronald Reagan UCLA Medical Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.